Subacute myelo-optic neuropathy (SMON) induced by antituberculous treatment in uraemia.
Donati
E
E
Department of Neurology, General Hospital, USSL 34, Chiari, Italy.
Bargnani
C
C
Besana
R
R
Locatelli
P
P
Faggi
L
L
De Marinis
S
S
D000328:Adult; D004977:Ethambutol / Q000008:administration & dosage / Q000009:adverse effects*; D005500:Follow-Up Studies; D005921:Glomerulonephritis / Q000150:complications*; D006801:Humans; D008297:Male; D009188:Myelitis, Transverse / Q000139:chemically induced*; D009460:Neurologic Examination; D009902:Optic Neuritis / Q000139:chemically induced*; D010292:Paresthesia / Q000139:chemically induced; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*; D014511:Uremia / Q000150:complications*; D014792:Visual Acuity / Q000187:drug effects
D004977:Ethambutol